3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27
Open Access
- 1 July 1999
- journal article
- Published by Elsevier
- Vol. 274 (31), 21926-21931
- https://doi.org/10.1074/jbc.274.31.21926
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cell Cycle ProgressionCirculation, 1998
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Cancer Cell CyclesScience, 1996
- Convergence of Mitogenic Signalling Cascades from Diverse Classes of Receptors at the Cyclin D–Cyclin-Dependent Kinase–pRb-Controlled G1 CheckpointMolecular and Cellular Biology, 1996
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductaseAtherosclerosis, 1993
- Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGFScience, 1991
- Regulation of the mevalonate pathwayNature, 1990